XML 25 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-based compensation
3 Months Ended
Mar. 31, 2017
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-based compensation

9. Stock-based compensation

In January 2017, the number of shares of common stock available for issuance under the 2013 Stock Option and Incentive Plan (“2013 Plan”) was increased by approximately 1.6 million shares as a result of the automatic increase provision of the 2013 Plan. As of March 31, 2017, the total number of shares of common stock available for issuance under the 2013 Plan was approximately 2.0 million.

Stock-based compensation expense

Stock-based compensation expense by award type included within the condensed consolidated statements of operations and comprehensive loss was as follows (in thousands):

 

 

Three Months Ended

March 31,

 

 

2017

 

 

2016

 

Stock options

$

9,342

 

 

$

8,926

 

Restricted stock units

 

1,956

 

 

 

1,127

 

Employee stock purchase plan

 

183

 

 

 

90

 

 

$

11,481

 

 

$

10,143

 

 

As of March 31, 2017, the Company had $121.7 million of unrecognized stock-based compensation expense related to unvested stock options, restricted stock units and the employee stock purchase plan, which is expected to be recognized over a weighted-average period of 2.8 years.

 

Stock-based compensation expense by classification included within the condensed consolidated statements of operations and comprehensive loss was as follows (in thousands): 

 

 

Three Months Ended

March 31,

 

 

2017

 

 

2016

 

Research and development

$

5,654

 

 

$

4,681

 

General and administrative

 

5,827

 

 

 

5,462

 

 

$

11,481

 

 

$

10,143

 

 

Stock options

The following table summarizes the stock option activity under the Company’s equity award plans (shares in thousands):

 

 

Shares

 

 

Weighted-average

exercise price

per share

 

Outstanding at December 31, 2016

 

3,735

 

 

$

52.17

 

Granted

 

696

 

 

$

76.37

 

Exercised

 

(181

)

 

$

15.18

 

Canceled or forfeited

 

(47

)

 

$

88.88

 

Outstanding at March 31, 2017

 

4,203

 

 

$

57.35

 

Exercisable at March 31, 2017

 

2,070

 

 

$

42.63

 

Vested and expected to vest at March 31, 2017

 

4,203

 

 

$

57.35

 

 

During the three months ended March 31, 2017, 0.2 million shares of common stock were exercised, resulting in total proceeds to the Company of $2.7 million. In accordance with the Company’s equity award plans, the shares were issued from a pool of shares reserved for issuance under the equity award plans.

Restricted stock units

The following table summarizes the restricted stock unit activity under the Company’s equity award plans (shares in thousands):

 

 

Shares

 

 

Weighted-average

grant date

fair value

 

Unvested balance at December 31, 2016

 

263

 

 

$

63.07

 

Granted

 

205

 

 

$

78.88

 

Vested

 

(39

)

 

$

50.08

 

Forfeited

 

(3

)

 

$

57.10

 

Unvested balance at March 31, 2017

 

426

 

 

$

71.92

 

 

Employee stock purchase plan

On June 3, 2013, the Company’s board of directors adopted its 2013 Employee Stock Purchase Plan (“2013 ESPP”), which was subsequently approved by its stockholders and became effective upon the closing of the Company’s IPO on June 24, 2013. The 2013 ESPP authorizes the initial issuance of up to a total of 238,000 shares of the Company’s common stock to participating employees. The first offering period under the 2013 ESPP opened on August 1, 2014. During the three months ended March 31, 2017 and 2016, 11,079 shares and 9,758 shares of common stock were issued under the 2013 ESPP, respectively.